April 11, 2013
AstraZeneca Pharmaceuticals LP settled its New Jersey patent infringement suit against Lupin Ltd. on Thursday, striking a deal in which Lupin agreed not to make or sell a generic version of AstraZeneca's extended-release schizophrenia drug Seroquel XR before November 2016.
November 09, 2012
AstraZeneca Pharmaceuticals LP has hit Lupin Ltd. with a patent infringement suit in New Jersey federal court, adding the India-based drugmaker to the long list of companies it has sued for trying to market generic versions of extended-release schizophrenia drug Seroquel XR.